Peer Interaction of Primiparas Sharing a Room With Multiparas With Successful Breastfeeding Experience
Launched by EGE UNIVERSITY · Feb 18, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how interactions between new mothers (primiparas) and experienced mothers (multiparas) can help improve breastfeeding success in hospitals. The goal is to create a peer support program where mothers who have breastfed successfully share their experiences and advice with new mothers who may need extra help. By doing this, the researchers hope to boost the confidence of new mothers in their breastfeeding abilities, making it easier for them to start and continue breastfeeding their babies.
To participate in this study, mothers must meet certain criteria. New mothers should be at least 18 years old and have had a single birth, while experienced mothers should have successfully breastfed at least one child for six months or more. Participants can expect to share a hospital room with another mother and take part in guided discussions about breastfeeding. The study will also assess how these peer interactions influence their feelings and confidence about breastfeeding. This trial aims to make peer support a regular part of hospital care for mothers, ultimately leading to better breastfeeding rates and outcomes for both mothers and their babies.
Gender
FEMALE
Eligibility criteria
- • Mothers to provide peer support
- • Multipar
- • Mothers with successful breastfeeding experience (Exclusive breastfeeding of the previous baby for at least 6 months, continued breastfeeding at the age of 2 years or older)
- • At least secondary education graduate
- • Singleton birth
- • Vaginal birth (due to rapid mobilisation after birth and quicker adaptation to daily activities)
- • with a child aged 5 years and under (limit for the age of the previous child for the memory factor regarding breastfeeding experience)
- • Breastfeeding self-efficacy scale score of 60 and above (out of a total score of 70)
- • No known or diagnosed psychiatric health problem in medical history
- • Women without any health problem that may prevent breastfeeding will be included.
- • Intervention-Control group mothers
- • Primipar
- • 18 years and over
- • Singleton birth
- • No known or diagnosed psychiatric health problem in medical history
- • Women who do not have any health problems that may prevent breastfeeding will be included.
- • Baby
- • Born between 37-42 weeks
- • Birth weight ≥2.5 kg and ≤3.9 kg
- • 1 and 5 minute Apgar scores ≥8
- • Not referred to neonatal intensive care unit
- Exclusion criteria for individuals/patients in the study:
- • Under 18 years of age
- • Non-literate in Turkish
- • Has a psychiatrically diagnosed health problem
- • Developing a health problem that may prevent breastfeeding
- • Taking medication that may jeopardise breastfeeding
- • Women who do not want to participate will not be included in the study.
- • Exclusion criteria
- • Requesting a room change
- • Not wanting to/wanting to stop peer interaction within the scope of the room arrangement
- • After settling in the room, those who did not want to answer the data collection tools for any reason/left the data collection tools unfinished
- • Mothers who could not be reached in the postnatal 1st month follow-up will be excluded from the study.
About Ege University
Ege University, a prestigious institution located in Izmir, Turkey, is renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, Ege University leverages its extensive academic resources and expertise in various healthcare fields to facilitate innovative clinical studies. The university is dedicated to enhancing patient care through rigorous research methodologies and collaboration with multidisciplinary teams, ensuring the development of effective therapies and interventions. With a strong focus on ethical standards and regulatory compliance, Ege University aims to contribute significantly to the global medical community by fostering groundbreaking discoveries and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Izmir, , Turkey
Patients applied
Trial Officials
Aysun Eksioglu, Assoc Prof
Principal Investigator
Ege University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported